Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

64 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Report from the OECI Oncology Days 2014.
van Harten W, Stanta G, Bussolati G, Riegman P, Hoefler G, Becker K, Folprecht G, Truini M, Haybaeck J, Buiga R, Dono M, Bagg A, López Guerrero J, Zupo S, Lemare F, de Lorenzo F, Goedbloed N, Razavi D, Lövey J, Cadariu P, Rollandi G, Paparo F, Pierotti M, Ciuleanu T, De Paoli P, Weiner G, Saghatchian M, Lombardo C. van Harten W, et al. Among authors: saghatchian m. Ecancermedicalscience. 2014 Dec 31;8:496. doi: 10.3332/ecancer.2014.496. eCollection 2014. Ecancermedicalscience. 2014. PMID: 25624877 Free PMC article.
Participation of Italian Cancer Centres of the Alleanza Contro Il Cancro (ACC) in the Organisation of European Cancer Institutes (OECI) Accreditation and Designation program: a successful first national initiative.
Oberst S, Boomsma F, Lombardo C, Docter M, Blaauwgeers H, De Paoli P, de Valeriola D, Paradiso A, Saghatchian M. Oberst S, et al. Among authors: saghatchian m. Tumori. 2015;101 Suppl 1:S6-9. doi: 10.5301/tj.5000464. Epub 2015 Dec 30. Tumori. 2015. PMID: 27098181
Actual costs of cancer drugs in 15 European countries.
van Harten WH, Wind A, de Paoli P, Saghatchian M, Oberst S. van Harten WH, et al. Among authors: saghatchian m. Lancet Oncol. 2016 Jan;17(1):18-20. doi: 10.1016/S1470-2045(15)00486-6. Epub 2015 Dec 4. Lancet Oncol. 2016. PMID: 26670093 No abstract available.
Analysing the attributes of Comprehensive Cancer Centres and Cancer Centres across Europe to identify key hallmarks.
Kehrloesser S, Oberst S, Westerhuis W, Wendler A, Wind A, Blaauwgeers H, Burrion JB, Nagy P, Saeter G, Gustafsson E, De Paoli P, Lovey J, Lombardo C, Philip T, de Valeriola D, Docter M, Boomsma F, Saghatchian M, Svoboda M, Philip I, Monetti F, Hummel H, McVie G, Otter R, van Harten W. Kehrloesser S, et al. Among authors: saghatchian m. Mol Oncol. 2021 May;15(5):1277-1288. doi: 10.1002/1878-0261.12950. Epub 2021 Mar 30. Mol Oncol. 2021. PMID: 33734563 Free PMC article.
Pioneering quality assessment in European cancer centers: a data analysis of the organization for European cancer institutes accreditation and designation program.
Saghatchian M, Thonon F, Boomsma F, Hummel H, Koot B, Harrison C, Rajan A, de Valeriola D, Otter R, Laranja Pontes J, Lombardo C, McGrath E, Ringborg U, Tursz T, van Harten W. Saghatchian M, et al. J Oncol Pract. 2014 Sep;10(5):e342-9. doi: 10.1200/JOP.2013.001331. Epub 2014 Aug 12. J Oncol Pract. 2014. PMID: 25118210
The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group.
El Bairi K, Haynes HR, Blackley E, Fineberg S, Shear J, Turner S, de Freitas JR, Sur D, Amendola LC, Gharib M, Kallala A, Arun I, Azmoudeh-Ardalan F, Fujimoto L, Sua LF, Liu SW, Lien HC, Kirtani P, Balancin M, El Attar H, Guleria P, Yang W, Shash E, Chen IC, Bautista V, Do Prado Moura JF, Rapoport BL, Castaneda C, Spengler E, Acosta-Haab G, Frahm I, Sanchez J, Castillo M, Bouchmaa N, Md Zin RR, Shui R, Onyuma T, Yang W, Husain Z, Willard-Gallo K, Coosemans A, Perez EA, Provenzano E, Ericsson PG, Richardet E, Mehrotra R, Sarancone S, Ehinger A, Rimm DL, Bartlett JMS, Viale G, Denkert C, Hida AI, Sotiriou C, Loibl S, Hewitt SM, Badve S, Symmans WF, Kim RS, Pruneri G, Goel S, Francis PA, Inurrigarro G, Yamaguchi R, Garcia-Rivello H, Horlings H, Afqir S, Salgado R, Adams S, Kok M, Dieci MV, Michiels S, Demaria S, Loi S; International Immuno-Oncology Biomarker Working Group. El Bairi K, et al. NPJ Breast Cancer. 2021 Dec 1;7(1):150. doi: 10.1038/s41523-021-00346-1. NPJ Breast Cancer. 2021. PMID: 34853355 Free PMC article. Review.
PARP Inhibitors in Breast Cancer: Why, How, and When?
Paradiso A, Andreopoulou E, Conte P, Eniu A, Saghatchian M. Paradiso A, et al. Among authors: saghatchian m. Breast Care (Basel). 2018 Jul;13(3):216-219. doi: 10.1159/000490746. Epub 2018 Jun 20. Breast Care (Basel). 2018. PMID: 30069183 Free PMC article. No abstract available.
64 results